APRIL KIENTZ: Open Payments
NPI 1063756765 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,902 in 98 payments from 16 companies in 2025. Trend: 2023 $43 · 2024 $2,020 · 2025 $1,902
Food & beverage: $1,802Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $322 |
| E.R. Squibb & Sons, L.L.C. | 20 | $303 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $218 |
| ABBVIE INC. | 16 | $207 |
| GENZYME CORPORATION | 6 | $175 |
| Janssen Biotech, Inc. | 9 | $143 |
| Regeneron Healthcare Solutions, Inc. | 3 | $95 |
| UCB, Inc. | 4 | $84 |
| Lilly USA, LLC | 4 | $78 |
| Amgen Inc. | 4 | $71 |
Products named: Sotyktu, COSENTYX, DUPIXENT, TREMFYA, SKYRIZI, ILUMYA, Bimzelx, RINVOQ.
Industry payments across KS — which companies pay providers there.
